SCHEMBL14218828

SCHEMBL14218828

C=C(C)C1CCC2(CC1)OOC1(CCC(CN3C(=O)c4ccccc4C3=O)CC1)O2

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.41
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
ACHE P22303 1/20 0.36
CYP1B1 Q16678 4/20 0.36
ADRB2 P07550 2/20 0.36
ADRB1 P08588 2/20 0.36
ADRB3 P13945 2/20 0.36
KDM4E B2RXH2 1/20 0.35
CYP3A4 P08684 1/20 0.35
GAA P10253 1/20 0.35
HPGD P15428 1/20 0.35
TRPA1 O75762 2/20 0.34
NPSR1 Q6W5P4 1/20 0.33
TP53 P04637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5109265 0.81 ATM (0.42) ALDH1A1CYP1A2CYP2C9CYP2C19ACHE
SCHEMBL21598055 0.78 CYP1A2 (0.51) ALDH1A1CYP1A2CYP2C9CYP2C19ACHE
SCHEMBL22725838 0.75 CYP2C9 (0.53) ALDH1A1CYP1A2CYP2C9CYP2C19ACHE
SCHEMBL31023116 0.73 CYP1A2 (0.49) ALDH1A1CYP1A2CYP2C9CYP2C19ACHE
SCHEMBL22725856 0.71 CYP2C9 (0.36) ALDH1A1CYP1A2CYP2C9CYP2C19ACHE
SCHEMBL1581709 0.71 CYP1B1 (0.59) ALDH1A1CYP1A2CYP2C9CYP2C19ACHE
SCHEMBL5109433 0.68 CYP1A2 (0.51) ALDH1A1CYP1A2CYP2C9CYP2C19ACHE
SCHEMBL21598051 0.67 CYP1A2 (0.54) ALDH1A1CYP1A2CYP2C9CYP2C19ACHE
SCHEMBL19406784 0.67 CYP1B1 (0.52) ALDH1A1CYP1A2CYP2C9CYP2C19ACHE
SCHEMBL28872170 0.67 CYP1B1 (0.52) ALDH1A1CYP1A2CYP2C9CYP2C19ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7371778-B2 Spiro and dispiro 1,2,4-trioxolane antimalarials MEDICINES FOR MALARIA VENTURE MMV (CH) 2008-05-13 US disclosed